Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Updated date |
Shortage status |
Dosage form:Injection, solution
Sponsor:Novo Nordisk Pharmaceuticals Pty Ltd
From15 Apr 2022to31 Dec 2022
Reason:Unexpected increase in consumer demand
Management action:A TGA web statement is available at https://www.tga.gov.au/alert/joint-statement-prioritisation-semaglutide-ozempic-supply-people-type-2-diabetes-during-shortage. Unregistered products have been approved for supply under Section 19A. The following approval holders can be contacted for details on supply: Medsurge Pty Ltd - 1300 788 261 and Pro Pharmaceuticals Group - 1300 077 674.
The Therapeutic Goods Administration is part of the Health Products Regulation Group